Doctor profile · Federal record
Dr. William Noyes, M.D.
Radiation Oncology Physician (CMS: Radiation Oncology) · Radiation Oncology Physician · Grand Forks, ND
- NPI 1649382292
- Accepts Medicare
- MIPS 87.5 / 100 · 2023
- 37 yrs in practice
- Licensed in 2 states
- Male
- Group practice
- No sanctions
Practice & contact
- Primary practice
-
1451 44Th Ave S, Unit E
Grand Forks, ND 582013434
(701) 787-5800
fax (701) 787-5802 - Mailing address
-
1451 44Th Ave S, Unit E
Grand Forks, ND 582013434
Credentials & registration
- NPI registered
- August 2006 — 20 yrs on file
- Profile last updated
- August 14, 2020
- Year of graduation
- 1989 — 37 yrs since
- Specialty taxonomy
- 2085R0001X — NUCC code
- State licenses (2)
- North Dakota #6918 · Minnesota #39673
- Medicaid (2)
- MN #965522100 · ND #18505
Federal sanctions & exclusions
No sanctions, exclusions or revocations on file
Checked against OIG LEIE on NPI 1649382292. Last verified May 11, 2026.Medicare procedures · 2023
Top services delivered
Total services
46,970
Distinct HCPCS
10
Medicare allowed
$1,472,615
| HCPCS | Description | Services | Patients | Avg allowed | |
|---|---|---|---|---|---|
Q5110 |
Injection, filgrastim-aafi, biosimilar, (nivestym), 1 microgram | 23,520 | 13 | $0 | |
J1439 |
Injection, ferric carboxymaltose, 1 mg | 13,500 | 17 | $1 | |
J9271 |
Injection, pembrolizumab, 1 mg | 5,203 | 14 | $54 | |
J2469 |
Injection, palonosetron hcl, 25 mcg | 990 | 31 | $1 | |
A9552 |
Fluorodeoxyglucose f-18 fdg, diagnostic, per study dose, up to 45 millicuries | 494 | 204 | $358 | |
J1100 |
Injection, dexamethasone sodium phosphate, 1 mg | 494 | 32 | $0 | |
78815 |
Nuclear medicine study from skull base to mid-thigh with ct scan | 477 | 199 | $1,487 | |
77014 |
Ct guidance for insertion of radiation therapy fields | 200 | 12 | $121 | |
96375 |
Injection of additional new drug or substance into vein | 176 | 50 | $15 | |
J3475 |
Injection, magnesium sulfate, per 500 mg | 168 | 26 | $1 |
In context: peer comparison
Among 2 peers in Grand Forks Radiation Oncology Physician, average services per provider: 943. This provider delivers 50× the peer median.Open Payments
Industry payments received
All-time total
$1,786
Transactions
41
Manufacturers
15
| Payer (manufacturer) | Industry | Txns | Amount |
|---|---|---|---|
| US Oncology Corporate, INC. | 4 | $841.68 | |
| Daiichi Sankyo INC. | 9 | $148.14 | |
| Janssen Biotech, INC. | 5 | $92.81 | |
| PharmaEssentia USA Corporation | 4 | $83.72 | |
| AstraZeneca Pharmaceuticals Lp | 2 | $49.31 | |
| Pfizer INC. | 3 | $46.95 | |
| Takeda Pharmaceuticals U.S.A., INC. | 2 | $44.27 | |
| Coherus Biosciences INC. | 2 | $39.38 | |
| Novartis Pharmaceuticals Corporation | 2 | $35.89 | |
| Myriad Genetic Laboratories, INC. | 2 | $33.27 | |
| BeiGene USA, INC. | 2 | $30.43 | |
| TerSera Therapeutics LLC | 1 | $24.13 | |
| Octapharma USA, INC. | 1 | $23.17 | |
| GlaxoSmithKline, LLC. | 1 | $22.41 | |
| Taiho Oncology, INC. | 1 | $20.72 |
By nature of payment
Medicare Part D · 2023
Top prescriptions
Total claims
65
Patients
0
Total drug cost
$1,142
| Drug | Type | Claims | Patients | Total cost |
|---|---|---|---|---|
| Tamsulosin Hcl | Generic | 23 | 0 | $245 |
| Bicalutamide | Generic | 17 | 0 | $336 |
| Alfuzosin Hcl ER (Alfuzosin Hcl) | Brand | 13 | 0 | $517 |
| Medroxyprogesterone Acetate | Generic | 12 | 0 | $44 |
Hospital affiliations
Frequently asked questions
What is Dr. William Noyes's medical specialty?
Dr. William Noyes practices Radiation Oncology Physician in Grand Forks, ND.
Where does Dr. William Noyes practice?
Dr. William Noyes practices at 1451 44Th Ave S, Grand Forks, ND 582013434. Office phone: 7017875800.
What is Dr. William Noyes's NPI?
Dr. William Noyes's National Provider Identifier (NPI) is 1649382292, issued by NPPES.
Does Dr. William Noyes accept Medicare assignment?
Yes. Dr. William Noyes accepts Medicare assignment, meaning Medicare-allowed amounts are accepted as full payment for covered services.
What procedures does Dr. William Noyes commonly perform?
Top Medicare-reported procedures in 2023: Injection, filgrastim-aafi, biosimilar, (nivestym), 1 microgram (HCPCS Q5110); Injection, ferric carboxymaltose, 1 mg (HCPCS J1439); Injection, pembrolizumab, 1 mg (HCPCS J9271). Source: CMS Medicare Physician & Other Practitioners file.